Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
KALV
Stock Latest News
Ratings
KalVista Pharmaceuticals: Strong Buy Rating Backed by Strategic Launch and Growth Prospects
11d ago
KALV
Premium
Ratings
KalVista Pharmaceuticals: Strategic Partnerships and Market Performance Justify Buy Rating
16d ago
KALV
Premium
Ratings
KalVista Pharmaceuticals: Strategic Licensing and Market Potential Drive Buy Rating
18d ago
KALV
Premium
Ratings
KalVista Pharmaceuticals: Strategic Partnership and Market Potential Drive Buy Rating
18d ago
KALV
Premium
Company Announcements
KalVista Pharmaceuticals Signs Agreement with Kaken Pharmaceutical
18d ago
8K
KALV
Premium
The Fly
KalVista subsidiary licenses commercialization rights for sebetralstat in Japan
18d ago
KALV
Premium
Ratings
KalVista Pharmaceuticals’ Strategic Readiness and Market Potential Drive Buy Rating for Sebetralstat
1M ago
KALV
Premium
Ratings
KalVista Pharmaceuticals: Promising Market Prospects for Sebetralstat with Imminent FDA Approval
1M ago
KALV
Premium
The Fly
KalVista completes enrollment in KONFIDENT-KID clinical trial of sebetralstat
1M ago
KALV
Premium
Ratings
Buy Rating for KalVista Pharmaceuticals Driven by Strategic Positioning and Market Potential of Sebetralstat
1M ago
KALV
Premium
Ratings
Buy Rating for KalVista Pharmaceuticals: Strong Regulatory Progress and Market Potential for Sebetralstat
1M ago
KALV
Premium
Ratings
Promising Potential of Sebetralstat: A Game-Changer in Hereditary Angioedema Treatment
1M ago
KALV
Premium
Ratings
Buy Rating for KalVista Pharmaceuticals Driven by Anticipated FDA Approval and Strong Market Position
1M ago
KALV
Premium
Company Announcements
KalVista Pharmaceuticals Advances Sebetralstat for HAE
1M ago
KALV
Premium
Ratings
KalVista Pharmaceuticals: Strategic Preparations and Financial Strength Underpin Buy Rating Amid Anticipated Sebetralstat Approval
1M ago
KALV
Premium
Ratings
Buy Rating for KalVista Pharmaceuticals Driven by Strong Financials and Promising Ekterly Launch
1M ago
KALV
Premium
The Fly
Morning Movers: iRobot plunges following Q4 results
2M ago
MX
ABM
Premium
The Fly
KalVista reports Q3 EPS (92c), consensus (87c)
2M ago
KALV
Premium
Pre-Earnings
KALV Earnings this Week: How Will it Perform?
2M ago
KALV
Premium
Ratings
KalVista Pharmaceuticals’ Sebetralstat: A Game-Changer in Oral HAE Treatment with Strong Market Potential
2M ago
KALV
Premium
The Fly
KalVista initiated with an Outperform at JMP Securities
3M ago
KALV
Premium
The Fly
KalVista granted orphan drug designation for sebetralstat by MHLW
3M ago
KALV
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
